Sap Vax

Developer of self-adjuvanting peptide vaccine immunotherapies for cancer

placeCleveland, Ohio, United States calendar_todayFounded 2016 groups4 employees language sapvaxllc.com

SapVax, LLC

Reg. No. 814730247United States

1 investor on record.

Investor type	Count	Share
Accelerator & incubator	1	100%

Coming soon